Project Details
Description
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (RELIANT)
| Status | Active |
|---|---|
| Effective start/end date | 7/27/20 → 7/31/25 |
Funding
- CORCEPT THERAPEUTICS INCORPORATED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.